Astellas Pharma Ltd. South Africa
Address: Gillooly’s View Office Park
5 Osborne Lane
Tel: +27(011) 615 9433
Astellas Pharma Ltd., was established as Yamanouchi Pharma in South Africa in June 2003. Prior to this, Yamanouchi operated as an agency for five years under the umbrella of Pharmaplan.
In South Africa, Astellas employs 27 people in 2011, of whom 16 are sales representatives. The company has established itself as a leading player in the therapy fields of Transplantation, Urology, and Dermatology.
Products and services
In order to realise Astellas‘ business philosophy to contribute towards improving the health of people around the world through the provision of innovative and reliable pharmaceutical products, VISION 2015 has been developed to represent Astellas‘ goals and aspirations for the future.
With VISION 2015, Astellas aims to become a Global Category Leader (GCL) in several therapeutic areas in which high unmet medical needs exist and a high degree of expertise is required. Astellas seeks to provide value-added healthcare products globally and enhance its enterprise value in a sustainable manner.
Recognising the emerging complexity and segmentation of the pharmaceutical marketplace, the Astellas global business model works to evolve and expand the company as a GCL in a variety of markets.
With insight and determination, Astellas will move to achieve GCL status by concentrating on six product categories of unmet medical needs, market potential, and research potential: Urology, Inflammation/Immunology, Infectious Diseases (including viruses), Neurology/Pain, Diabetes, and Oncology.